2011年SBF首次会议：全球药品研发与种族性|2011-4-7|复旦大学公共卫生学院

Shanghai Biostatistics Forum (SBF) 1st Event, 2011
' V- {8 o/ |0 @9 C6 U, o
( W0 U( v7 U* k1 ^. R6 }The first SBF event in 2011 will be held on Apr 7, hosted by Fudan Univ School of Public Health.  The theme will be "Global Drug Development and Ethnicity".The agenda is below. We are looking forward to meeting you.

; }7 c" V, h( e2 H1 c7 E  ODate and Time:   
% ?0 V1 B9 J. L* o+ S, S- A+ _7 M) ?Thursday, April 07, 2011, 1:30-5:30pm

7 ~* ~3 y/ S; H9 [1 yLocation :   
' P* }/ ]; f. H6 t+ G% GTeaching Building #2, Room 2201 , Fenglin Campus, Fudan University (direction below)
上海市东安路130号 [复旦大学枫林校区西园第二教学楼 201教室] (详细地址见下)  
3 k  m) n  m6 D; Q4 L
+ w; E/ J, `4 OLocal Sponsor:  
School of Public Health, Fudan University
& V5 I2 X1 F: G9 V+ Z& t$ tAttendee:
Open to everyone who is interested.  
- |5 e; }! x4 y8 _1 p5 `$ Y4 c' [: CTheme: Global Drug Development and Ethnicity
( {* f- [$ S& h: G+ fAgenda:  
ƒ  Introduction and  Welcome Remarks
2 y8 r- J: k- P. u; G9 CDr William Wang, Head of the Asia Pacific Hub,  Biostatistics and Research Decision
Sciences, Merck Research Laboratories, Merck & Co Inc
- f/ m1 \7 C6 a. XProfessor Naiqing Zhao,  School of Public Health, Fudan University
ƒ  Presentations:  
1.  Asian Ethnicity and Drug Development-Regulatory Risk       45 min
Dr Robert (Bob) Powell,  Scientific Advisor, Roche China Inc and Former Director of   
Pharmacometrics & Associate Director, Office of Translational Sciences, CDER, US FDA
2.  On Sample Size Calculation in Multi-Regional Trials & the Japan Experiences  45 min
Dr Eckhard Pecher, Head  Integrated Information Sciences (IIS) Japan & China, Novartis;
3 [3 d; L8 X; A: aDr Wei Zhang,  Senior Principal Biostatistician, Novartis China
& b5 }4 Q) ?$ L% q, Z. u3.  A Bridge Too Far? Challenges and Opportunities in Linking China into  
% V. v$ n0 j3 S; a& j! LSimultaneous Global Development via Multi-Regional Clinical Trials     45 min
Dr Frank Shen, Asia Pacific Head of GPD Biometrics,  Roche China
6 C+ s+ c+ e, }8 N3 fƒ  Panel Discussion:  Global Drug Development in China        75 min